Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05690269 · ClinicalTrials.gov registry record
Oximeters and Skin Pigment: Impact of Skin Pigmentation on Accuracy of Pulse Oximetry
A clinical trial of Hypoxemia and Hyperoxia, sponsored by University of Cincinnati.
- Completed
- Registry status
- 232
- Enrollment target
- 1
- Study location
NCT05690269: Completed study of Hypoxemia and Hyperoxia, sponsored by University of Cincinnati.
NCT05690269 is a study of Hypoxemia and Hyperoxia that has completed, run by University of Cincinnati. The registered enrollment target is 232 participants, below the 472-participant average among 10 other Hypoxemia trials with a reported enrollment target (51% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05690269, a study of Hypoxemia and Hyperoxia, has completed, sponsored by University of Cincinnati.
- COMPLETED
- Registry status
- 232 participants
- Enrollment target
- 1
- Study location
Study Summary
Finger pulse oximetry SpO2 is widely used to estimate arterial oxygen saturation SaO2. Current Spo2 targets do not take into consideration the many variables that affect that correlation in particular skin pigmentation. This study aims to evaluate different FDA approved pulse oximeters (Nonin co-pilot, massimo Radical 7, Philips-standard of care monitor, innovo premium iP900BP, nellcor PM1000N, Nano100) with SaO2 reference values obtained by an arterial blood gas in subjects with different skin pigments measured by a skin color scale as well as self-identification of race.
Primary Outcome
Difference between oximeter SpO2 and the corresponding SaO2 value
Conditions Studied
Interventions
- DEVICE SpO2 and SaO2 comparison
Study Locations (1)
Ohio
- University of Cincinnati - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 232 participants |
| Start Date | 2023-02-27 |
| Est. Completion | 2025-03-31 |
What the finished NCT05690269 record still lists
NCT05690269 is an observational study that tracks outcomes without assigning an intervention. The registered 232 participants enrollment target is mid-sized for trials with a published cap, below the 472-participant average among 10 other Hypoxemia trials with a reported enrollment target (51% lower).
The record links to 3 conditions, with Hypoxemia appearing as the primary indexed condition, and to 1 intervention - of which SpO2 and SaO2 comparison is the first listed.
NCT05690269 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT05690269 about?
NCT05690269 is a clinical study titled "Oximeters and Skin Pigment: Impact of Skin Pigmentation on Accuracy of Pulse Oximetry". Finger pulse oximetry SpO2 is widely used to estimate arterial oxygen saturation SaO2. Current Spo2 targets do not take into consideration the many variables that affect that correlation in particular skin pigmentation. This study aims to evaluate different FDA approved pulse oximeters (Nonin co-pi...
What is the current status of trial NCT05690269?
This trial is currently completed. The enrollment target is 232 participants. The study started on 2023-02-27. Estimated completion is 2025-03-31.
What conditions does trial NCT05690269 study?
This clinical trial studies the following conditions: Hypoxemia, Hyperoxia, Pigment Skin.
What interventions are being tested in trial NCT05690269?
The interventions under investigation include: SpO2 and SaO2 comparison (DEVICE).
Who is sponsoring clinical trial NCT05690269?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05690269 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypoxemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05690269's enrollment target sits among peer trials
232 3rd of 10 higher than 8 of 10 other Hypoxemia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypoxemia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Postoperative Respiratory and Activity Monitoring
RECRUITING
-
Skin Pigment/Pulse Oximeter in Congenital Heart Disease (CHD)
RECRUITING
-
Optimizing Care in Critically Ill at UCHealth by Liberalizing the Target O2 in Mechanically-ventilated ICU Patients
RECRUITING · NA
-
Investigation of Skin Pigmentation Effect on Performance of Masimo Pulse Oximetry (INSPIRE)
RECRUITING · NA
-
Inhaled Treprostinil (Tyvaso Nebulizer) For COPD Patients With Hypoxemia
RECRUITING · Phase 2
-
Work of Breathing Assessment in Triage Scale
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01356290 · 232 participants · Phase 2
Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors
- NCT04753359 · 232 participants · NA
Mediterranean Diet and Weight Loss: Targeting the Bile Acid/Gut Microbiome Axis to Reduce Colorectal Cancer
- NCT04770870 · 232 participants · NA
Post Approval Study2: Hintermann Series H3 Total Ankle Replacement System
- NCT05948943 · 232 participants · Phase 2
Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI